Rare diseases and the power of precision medicine
15 December, 2017 by Mansi GandhiWhen molecular biologists Steve Wilton and Sue Fletcher first started exploring dystrophin exon skipping for Duchenne muscular dystrophy (DMD), they faced a lot of scepticism.
Nearly 40% of Australian cancer deaths are potentially preventable
15 December, 2017Queensland researchers have found that 38% of cancer deaths in Australia, or 16,700 each year, could potentially be avoided — mostly through lifestyle changes.
Light-activated glue seals wounds in 60 seconds
14 December, 2017 by Bec CrewAustralian scientists have invented a gel that seals wounds and stops bleeding — both internally and externally — within 60 seconds. It sends signals to the body to start repairing the wound — at twice the regular speed.
Gene editing — one reagent doesn't fit all
13 December, 2017Person-to-person genetic differences may undercut the efficacy of the gene editing process or, in more rare cases, cause a potentially dangerous off-target effect, warn researchers.
Engineering yeast to create protein pharmaceuticals
12 December, 2017Researchers, headed by Professor Jens Nielsen at Chalmers University of Technology, have successfully mapped out the complex metabolism of yeast cells.
Tumour-suppressive protein patrols metastatis sites
12 December, 2017Belgian researchers have labelled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer, describing the 'anti-metastatic surveillance' role of the protein for the first time.
Nearly 6% of cancers attributable to diabetes, high BMI
06 December, 2017UK researchers have revealed that diabetes and high body-mass index were the cause of 5.6% of new cancer cases worldwide in 2012 — equivalent to 792,600 cases.
Patient enrolment for CSL's biggest heart attack trial to begin in early 2018
06 December, 2017Australian-listed global bio-therapeutics company CSL has confirmed a Phase 3 clinical trial for CSL112, the company's novel therapy for reduction of early recurrent cardiovascular events in heart attack survivors.
LeafCann and WardMM partner for BPSD clinical trial
30 November, 2017LeafCann Research and Advisory has signed a clinical trial agreement with WardMM to sponsor and provide medicinal cannabis extracts for the latter's research and development program for the treatment of behavioural and psychological symptoms of dementia (BPSD).
Griffith Uni celebrates new biobanking resource, MoU with Gold Coast Health
28 November, 2017Griffith University is discussing a number of its recent initiatives as part the Gold Coast Health Research Week Conference.
New TGA rules assist access to medical cannabis
24 November, 2017The TGA has announced changes to its Special Access Scheme that will make it easier for medical practitioners to prescribe cannabis-based medicines for patients in need, under certain conditions.
Biomarkers — a silver bullet to cancer diagnosis and treatment, report
21 November, 2017Fast-tracking biomarker research has the potential to transform cancer diagnosis and treatment, according to a report by the University of South Australia's Sansom Institute.
Experts meet to discuss potential of particle therapy for cancer
13 November, 2017Medical and health experts from across Australia and New Zealand recently convened in Adelaide to discuss the way forward for particle therapy in Australia.
Zero Childhood Cancer program comes to WA
10 November, 2017The Zero Childhood Cancer program — said to be one of the world's most comprehensive child cancer personalised medicine studies — has finally reached Western Australia, seven weeks after its national launch.
Award-winning wearable sensor technologies could transform personalised medicine
06 November, 2017ANU has announced the winner of its inaugural Grand Challenge Scheme — a $50 million initiative to provide funding for transformative research with the potential to radically change our understanding of, and responses to, the world's most intractable problems.
